Merck KGaA
MKGAF·OTC·Life Sciences·CIK 0001764133
Merck KGaA is a science and technology company operating in Europe, North America, Latin America, the Middle East and Africa, and the Asia Pacific. It reports three business segments. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector, including reagents, consumables, devices, instruments, software, and services for research, production, and testing, lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. It also provides traditional and novel therapies such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing, plus contract development, manufacturing and testing services supporting customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals in oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; delivery equipment for handling specialty chemicals and gases for semiconductor manufacturing; technologies for modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. Merck KGaA has an in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor, and a strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.